4 participants
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-10-19
- Start Date:
- 2014-11-20
- Completion:
- 2016-10-11
Conditions
- Lymphoma
- Primary Central Nervous System Lymphoma
- Recurrent/Refractory Secondary Central Nervous System Lymphoma
Interventions
- DRUG